| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total interest and other income (expense), net | 8,739 | -128,602 | ||
| Loss from operations before provision for income taxes | -2,316,786 | -1,733,430 | ||
| Provision for income taxes (note 9) | 250 | 1,500 | ||
| Net loss | -2,317,036 | -1,734,930 | ||
| Net loss noncontrolling interest | -712 | -1,204 | ||
| Net loss attributed to 60 degrees pharmaceuticals, inc | -2,316,324 | -1,733,726 | ||
| Basic (in dollars per share) | -0.66 | -1.25 | ||
| Basic (in shares) | 3,675,407 | 1,472,891 | ||
| Diluted (in dollars per share) | -0.66 | -1.25 | ||
| Diluted (in shares) | 3,675,407 | 1,472,891 | ||
60 DEGREES PHARMACEUTICALS, INC. (SXTPW)
60 DEGREES PHARMACEUTICALS, INC. (SXTPW)